Literature DB >> 6657732

Nicotine as a reinforcer in human subjects and laboratory animals.

J E Henningfield, S R Goldberg.   

Abstract

Results are summarized from 17 studies in which intravenous nicotine was evaluated in self-administration paradigms. Six species, ranging from the albino rat to the human, have been tested under a variety of schedules of reinforcement, and as a function of several pharmacologic manipulations. Under certain environmental conditions, it is clear that nicotine can serve as a reinforcer. However, nicotine differs from many other drugs of abuse in that the range of environmental conditions under which it serves as a reinforcer appears to be more restricted.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6657732     DOI: 10.1016/0091-3057(83)90405-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  62 in total

Review 1.  Vaccines against nicotine: how effective are they likely to be in preventing smoking?

Authors:  F J Vocci; C N Chiang
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Nicotine dependence: a preventable risk factor for other diseases.

Authors:  C Cohen; J E Henningfield
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

3.  Nicotine reinforcement in never-smokers.

Authors:  Angela N Duke; Matthew W Johnson; Chad J Reissig; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

4.  Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.

Authors:  Xia Li; Manoranjan S D'Souza; Ana M Niño; James Doherty; Alan Cross; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2016-02-13       Impact factor: 4.530

Review 5.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

6.  Behavioral economics of drug self-administration. IV. The effects of response requirement on the consumption of and interaction between concurrently available coffee and cigarettes.

Authors:  W K Bickel; J R Hughes; R J DeGrandpre; S T Higgins; P Rizzuto
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.

Authors:  Matthias E Liechti; Athina Markou
Journal:  Eur J Pharmacol       Date:  2006-10-17       Impact factor: 4.432

8.  Electrophysiological actions of nicotine on substantia nigra single units.

Authors:  P B Clarke; D W Hommer; A Pert; L R Skirboll
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

Review 9.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Authors:  Eric C Donny; Melissa Jones
Journal:  Drug Alcohol Depend       Date:  2009-05-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.